KAYLA WARNER: Open Payments
NPI 1184192858 · PICAYUNE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,393 in 115 payments from 36 companies in 2025. Trend: 2023 $597 · 2024 $330 · 2025 $2,393
Food & beverage: $2,318Education: $75
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $178 |
| Merck Sharp & Dohme LLC | 8 | $172 |
| E.R. Squibb & Sons, L.L.C. | 9 | $159 |
| PFIZER INC. | 8 | $152 |
| Daiichi Sankyo Inc. | 4 | $111 |
| Celgene Corporation | 5 | $105 |
| Gilead Sciences, Inc. | 2 | $104 |
| Geron Corporation | 5 | $101 |
| BeOne Medicines USA, Inc. | 4 | $99 |
| Incyte Corporation | 4 | $92 |
Products named: KEYTRUDA, Trodelvy, RYTELO, REBLOZYL, Enhertu, KISQALI, clonoSEQ, OJJAARA.
Industry payments across MS — which companies pay providers there.
